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Abstract 
Objective: Fine needle aspiration biopsy (FNAB) can cause reactive 
histopathological changes including commonly haemorrhage and granulation tissue. 
Literature describing vascular proliferation after FNAB is sparse. We aimed to 
describe neovascularization in the thyroid gland specimens as a consequence of 
FNAB. 
Study Design: We analysed all thyroid histopathological specimens from the Fimlab 
Laboratories within 2010-2013 for neovascularization and distortions in the 
accompanying tissue. We evaluated HE-stained slides and CD31, podoplanin and Ki-
67 immunostained slides. 
Results: We observed vascular proliferation in 64 specimens (out of 787 specimens, 
8,1%). In these patients the mean age was 62 years; 43 were females and 21 males. A 
previous FNAB data were available in 49 cases (76.6%). In 51 cases (79.7%), the 
neovascularization occupied less than 5% area. The vessel dilatation was moderate in 
28 cases (43.8%) and low in 20 cases (31.3%). In tumours, neovessels were detected 
within the tumour and in surrounding tissue.  
Conclusions: Post-FNAB tissue samples include dilated newly formed vessels, which 
pathologists should differentiate from rare thyroid vascular tumours. The proposed 
mechanism is traumatically induced haemorrhage followed by hematoma and 
thrombosis that resolves by re-canalization. The knowledge of tissue alteration is 
needed to avoid misdiagnoses.  
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Introduction 
Fine needle aspiration biopsy (FNAB) of the thyroid gland is a well-established, safe 
and rapid method for the management of thyroid nodules [1, 2]. Thyroid FNAB is 
useful to select the patients who need surgical treatment [3, 4]. Clinical complications 
of FNAB include hematoma formation and acute airway obstruction, which are 
fortunately uncommon [5, 6]. 
Previous studies characterise FNAB needle tract related histopathological changes in 
various organs, including lymph nodes, salivary glands, parathyroid glands and breast 
[7, 8, 9, 10]. The most common change is infarction or necrosis [11, 12, 13]. 
Dissemination of malignant cells during FNAB is rare as reviewed by Polyzos and 
Anastasilakis [14]. 
LiVolsi and Merino described worrisome histologic alternations following thyroid 
FNAB (WHAFFT) in 1994 [15]. Several following studies confirmed their 
observations [16, 17, 18, 19]. Thyroid FNAB related histopathological changes often 
include haemorrhage, fibrosis, granulation tissue, and necrosis [15, 16, 17, 18, 20, 21]. 
Necrosis and infarction of the thyroid gland had been already described before the 
WHAFFT concept mainly as case reports and case series [22, 23].  
Vascular changes as a consequence of FNAB have been described sparsely [15, 16, 
17, 24, 25]. They include hemangioma-like vascular proliferation, angiosarcoma-like 
proliferation, papillary endothelial hyperplasia and thrombosis with recanalization 
[17, 16, 20]. Notably, thyroid vascular tumours as hemangioma and angiosarcoma are 
remarkably rare [26]. 
The present study aimed at describing the frequency and histopathological 
characteristics of vascular proliferation in the thyroid gland histopathological 
specimens and its possible relation to the previous FNAB. We present a detailed 
analysis of 64 cases from a 4-year-period. 
 
  
Materials and Methods 
The study was conducted at the Department of Pathology, Fimlab Laboratories, 
Tampere University Hospital and was approved by the local Ethical Committee. We 
reviewed all total thyroidectomy and thyroid lobectomy samples obtained between 
January 2010 and December 2013 (n=787) for vascular proliferation. The surgical 
specimens were routinely fixed in 10% formalin and processed into paraffin blocks. 
The tumour cases were totally blocked. In goitre cases all nodules were sampled, there 
was a minimum of 3 blocks per lobe. Four-µm-sections were stained with 
haematoxylin-eosin. We performed additional immunostainings with primary 
antibodies detecting the endothelium (CD31, dilution 1:400, clone JC70A, DAKO 
Denmark, Glostrup, Denmark), lymphatic endothelium (podoplanin, dilution 1:200, 
clone D2-40, DAKO Denmark, Glostrup, Denmark) and proliferation (Ki-67, clone 
MIB-1, dilution 1:200, DAKO Denmark, Glostrup, Denmark). We used a fully 
automated immunostaining system (Bondmax, Leica Biosystems Newcastle Ltd., 
Newcastle upon Tyne, United Kingdom). 
Neovascularization was further analysed for the localization within the thyroid gland, 
the total area and the dimension of the vessels as well as endothelial characteristics. 
Also, we evaluated the presence of haemorrhage, thrombosis, fibrin deposits, oedema, 
fibrosis, necrosis, granulation tissue and cystic degeneration in the tissue around the 
neovessels.  
We used IBM SPSS (version 21.0) for statistical analysis. Significant associations 
were defined using the chi-square test. 
 
  
Results 
Out of 787 thyroid specimens, vascular proliferation was found in 64 cases (8.1%). 
The study population consisted of 43 females and 21 males aged 21-88 years (mean 
62 years). The histopathological diagnoses were papillary carcinoma in 6 cases, 
follicular carcinoma in 7 cases, follicular adenoma in 25 cases, and nodular goitre in 
26 cases. In addition to above listed main diagnoses, Hashimoto thyroiditis was 
diagnosed in 16 cases. Oncocytic metaplasia was found in 28 cases, out of which 
oncocytic tumour variants were oncocytic papillary carcinoma in 3 cases, oncocytic 
follicular carcinoma in 4 cases and oncocytic follicular adenoma in 15 cases.  
Data on preceding FNAB date and diagnosis was available in 49 cases (76.6%). The 
frequency of FNAB availability and the distribution of the main diagnoses are 
comparable between studied cases and the rest of the department specimens. 
Radiologists performed ultrasound-guided FNABs with 22-gauge needles. In 40.8% 
of the cases, FNAB was taken less than two months before the surgery, in total, the 
FNAB time frame ranged from one month to two years. The dilatation of neovessels 
correlated with FNAB time span, but no statistical difference was found for total 
vessel area. In nine cases, FNAB was repeatedly taken twice and in one case three 
times. The data was unavailable in 15 cases (23.4%), because information was not 
available for FNABs obtained in private clinics or other regions. 
The observed vessels were capillaries, venules and arterioles. The shape of vessels 
was irregular and dilated. Vessels were mainly clustered (Fig 1a-f). The endothelium 
was positive for pan-endothelial marker CD31 (Fig 1g-j), but negative with lymphatic 
endothelium marker podoplanin (Fig 1k) [27]. We did not find mitoses or nuclear 
atypia in the endothelium. No proliferation activity was seen as detected with Ki-67 in 
the endothelium and the tissue surrounding vascular structures (Fig 1l). 
The newly formed vessels were characterized by dilatation, branching and sprouting 
with local endothelial irregularities. The areas of neovessels varied among the cases. 
Only in one case, the area reached 80% of the thyroid gland tissue sections.  In 51 
cases (79.7%), the neovascularization occupied less than 5% thyroid gland area.  In all 
cases without the FNAB data, the area was <5% and accompanying changes were 
limited. Of note is that, in 34.7% with FNAB data available, the neovascularized area 
was 5% (p=0.008). According to the main diagnoses, in 21 nodular goitres out of 24, 
the area was less than 5%. 
We assessed the vessel dilatation into three grades. We found high-grade vessel 
dilatation in 16 cases (25.0%), moderate grade in 28 cases (43.8%) and low grade in 
20 cases (31.3%). The accompanying inflammatory infiltrates of Hashimoto 
thyroiditis did not influence the vessels characteristics, dilatation, or total area. In fact, 
the neovessels were not localized in the inflammatory areas. 
We found vascular changes within the tumour in 92.0% of adenomas and 61.5% of 
carcinomas (p<0.001). Surrounding tissue harboured vascular changes less often, but 
still with remarkable frequency. Similarly, in nodular goitres, we found 
neovasculature within the nodules. 
In the majority of those cases, where we observed haemorrhage (90.6%), oedema 
(84.4%), fibrin deposits (79.7%) and cystic degeneration (65.6%), the FNABs were 
taken in less than two months before the surgery. Figure 2 shows clustering of the 
changes (Fig 2). 
Surprisingly, we found thrombosis only in 4 cases (6.3%) (Fig 1f) and necrosis in 3 
cases (4.7%). Necrotic lesions did not correspond to areas with oncocytic metaplasia. 
We observed fibrosis in 32.8% of the cases. 
 
Discussion 
The thyroid gland is a highly vascularized organ [28]. Vascular endothelial growth 
factor (VEGF) levels are also high in the thyroid tissue [29]. The diagnostics of 
thyroid vascular lesions is not straightforward. The heterogeneous disease spectrum 
consists of reactive lesions like benign endothelial proliferation, benign hemangiomas 
and extremely rare malignant angiosarcomas [26]. Table 1 represents a literature 
review of thyroid hemangiomas (Table 1). Outside the endemic alpine area, 
angiosarcomas and malignant haemangioendotheliomas are uncommon [44, 45]. 
Table 2 summarises various nontumorous vascular lesions, which are not related to 
FNAB (Table 2) [46, 47, 48, 49]. 
Several studies have described the relation of FNAB and vascular proliferation [15, 
16, 17, 24, 25, 18] (Table 3). In WHAFFT concept article, however, only dilated 
vessels were mentioned [15]. Erzos et al. found vascular proliferation and thrombosis 
in 45% of thyroids that were aspirated, but they did not find these changes in non-
aspirated cases [16]. On the contrary, Bolat reported vascular changes only in 2.7% of 
studied thyroids [18]. In another series, 10 thyroids out of 102 showed vascular 
changes lead by the thrombosis and recanalization in 5 cases [17]. Of note is that, all 
the cases of vascular changes were associated with necrosis in contrast to our data. 
Our own necrosis reported cases were not accompanied by neovascularization [21]. 
Interestingly, Pandit showed also angiosarcoma-like alterations in a specimen 147 
days after FNAB [17]. Erzos et al. [16] did not report nuclear pleomorphism and 
mitotic figures, which is in agreement with our results. In some cases, plump 
endothelial cells and endothelial hyperplasia mimic vascular tumours [26, 7]. 
Due to high vascularity, the thyroid gland is susceptible to a haematoma [24, 16]. The 
proposed mechanism of the neovascularization is a needle-induced haemorrhage 
followed by a haematoma and thrombosis that resolves by re-canalization and vessel 
formation (Figure 3). Additionally, Pandit suggested that also fibroblastic 
proliferation, not only vascular, is caused by needle trauma [17].  Traumatization by 
palpation and surgery is a less probable explanation [24]. Sapino et al. described 
spontaneous haemorrhage in long-standing goitre nodules [48]. This observation is in 
agreement with our results, as FNAB history was negative/unavailable in 15 cases in 
our series.  Sharma and Krishnanand speculated about the role of FNAB technique in 
the aetiology of vascular proliferation: they found a 21-gauge needle less traumatic 
than other options [19]. The numerous and multiple needle passes increase vascular 
proliferation development and capsular pseudo-invasion [15, 20] that interferes with 
follicular adenoma versus carcinoma diagnostics. In our personal experience, the 
neovascularization did not interfere with the measurements of nodule/tumor size. 
In the literature, needle tract effect after repeated thyroid FNAB was also described in 
cytological specimens. In a study by Recavarren et al., 16 cases of Bethesda atypia of 
undetermined significance (AUS/FLUS) in repeated FNAB was found [51]. They 
found two samples with atypical stromal, endothelial and follicular cells embedded in 
blood or blood clots, probably induced by previous FNABs.  In our opinion, revision 
of previous slides is necessary to avoid inaccuracies in diagnostics. The cases may 
nevertheless be categorised into the AUS/FLUS heterogeneous group [52]. 
Core needle biopsy (CNB) provides an alternative diagnostic method in nondiagnostic 
and AUS/FLUS cases [53]. However, thyroid CNB is not widely used in clinical 
practise. The commonest clinical complication is haematoma formation [54, 55]. We 
suspect that the CNB procedure can cause similar and even worse histopathological 
alterations than the FNAB procedure. 
In conclusions, post FNAB changes are often accompanied by dilated newly formed 
vessels.  Proper histopathological diagnostics requires the knowledge of reactive  
post-FNAB tissue alterations and patient history of FNAB to avoid misdiagnosis. 
Pathologists should differentiate reactive vascular changes from rare thyroid vascular 
tumours. In the clinical practice, the differential diagnosis with angiosarcoma is of 
paramount importance. However, a secondary hemangioma caused by the 
organisation of a hematoma is almost impossible to distinguish from a real 
hemangioma [26]. Nevertheless, the phenomenon of neovessels is quite rare in thyroid 
gland specimens. 
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Figure 1 Co-presence of haemorrhage, oedema, fibrin deposits and cystic
degeneration with vascular proliferation in presented study.
Figure 2 Histopathological and immunohistochemical characteristics of vascular proliferation: 
a. Dilated thin-walled capillaries surrounded by haemorrhage and cystic degeneration in nodu-
lar goitre (haematoxylin-eosin, magnification 40×), b. Dilated mainly blood-filled capillaries in a 
fibrin-rich hemorrhagic area in nodular goitre (haematoxylin-eosin, magnification 40×), c. Dilated 
vessels with fibrin-rich walls represent arteriole/venule levels. The case of follicular adenoma. 
(haematoxylin-eosin, magnification 20×), d. Area of oedema, haemorrhage and onion-like fibrin 
deposits surrounding dilated capillaries in follicular adenoma (haematoxylin-eosin, magnification 
20×), e. Clusters of dilated capillaries in a hemorrhagic area in an oncocytic variant of follicular 
adenoma (haematoxylin-eosin, magnification 40×), f. A thrombotic vessel in the vicinity of papil-
lary carcinoma (haematoxylin-eosin, magnification 100×), g. Thick-walled fibrin-rich CD31-pos-
itive vessels in follicular carcinoma (CD31 immunohistochemistry, 40×), h. Numerous irregular 
venules or arterioles revealed CD31-positivity in nodular goitre (CD31 immunohistochemistry, 
40×), i. Dilated irregular capillaries showed features of branching in another goitre case (CD31 
immunohistochemistry, 100×), j. Irregular thickened walls of newly formed vessels in goitre case 
(CD31 immunohistochemistry, 200×), k. No lymphatic vessels were found in vessel-rich areas 
(podoplanin- immunohistochemistry, 100×), l. Proliferation activity as detected with Ki-67 anti-
body was sparse in newly formed vessels (Ki-67 immunohistochemistry, 100×).
Figure 3 Mechanism of Vascular Proliferation Development
Table 1 Thyroid gland hemangiomas  
Citation Pathological Diagnosis Size (cm) Sex Age FNA 
history 
Histologically 
verified  
Pickleman et 
al. [30]  
primary 
hemangioma/hemangioma 
NOS 
7,5X3X2 M 56 no yes 
Pendse et al. 
[31]  
primary hemangioma 6X3,5 M 53 yes yes 
Kumar et al. 
[32] 
primary hemangioma 4X4 M 53 no yes 
Rios et al. [33] cavernous hemangioma 5X4 F 48 no yes 
Rios et al. [33] cavernous hemangioma 5X3 F 63 no yes 
Kano et al. 
[34] 
cavernous hemangioma 5,5X3,0X2,0 M 21 no yes 
Hassan et al. 
[35] 
epithelioid 
hemangioendothelioma 
5,0X8,0X4,0 F 73 - yes 
Lee et al. [36] cavernous hemangioma 17,0X16,5 M 66 no yes 
Datta et al. 
[37]  
cavernous hemangioma 4,9X4,4 M 25 no yes 
Ciralik et al. 
[38]  
cavernous hemangioma 7X6X6 M 64 no yes 
Sakai et al. 
[39] 
cavernous hemangioma 5,2X4,8X3,5 F 71 no yes 
Michalopoulos 
et al. [40]  
cavernous hemangioma 3,7 M 78 no yes 
Gutzeit et al. 
[41]  
cavernous hemangioma 4 F 84 no yes 
Maciel at al 
[42] 
cavernous hemangioma 22X21X17 F 80 no yes 
Dasgupta et al. 
[43]  
cavernous hemangioma 4,5X4 M 38 no yes 
 
 
Table 2: Nontumorous vascular changes not related to FNA 
 
Citation Pathological Diagnosis 
of vascular lesion 
Number 
of cases 
Co-existing thyroid pathology FNA history 
Tse et al. 
[46]  
Capsular intravascular 
endothelial hyperplasia 
3 Follicular carcinoma (n=2) 
Papillary carcinoma (n=1) 
1 (33%) 
Schmitz et 
al. [47] 
Florid capsular and 
pericapsular papillary 
endothelial 
proliferation 
1 Poorly differentiated 
carcinoma 
1 (100%) 
Sapino et 
al. [48]  
Intranodular reactive 
endothelial hyperplasia 
11 Adenomatous goitre 1 (9%) 
Baloch and 
LiVolsi 
[49] 
Intravascular Kaposi´s-
like spindle cell 
proliferation  
3 Follicular carcinoma (n=3) 
including oncocytic variant 
(n=2) 
1 (33%) 
 
Table 3 Vascular Proliferation after Thyroid FNAB: Review of Literature 
Source All 
case
s (n) 
Vascula
r 
changes 
cases in 
total (n) 
Vascular 
proliferatio
n (n) 
Vascular 
thrombosi
s (n) 
Papillary 
endothelial 
hyperplasi
a 
Plump 
endothelia
l cells 
Ersöz et al. 
[16] 
20 9 (45%) 9 (45%)* 9 (45%)* N.D. N.D. 
Pandit and 
Phulpagar 
[17] 
265 10 
(3.8%) 
2 (0.7%) 5 (4.9%) 3 (2.9%) N.D. 
Tsang and 
Duggan [24] 
2 2 
(100%) 
2 (100%) 2 (100%) 2 (100%) 2 (100%) 
Sharma and 
Krishnanand 
[19] 
100 23 
(23%) 
4 (4%) 20 (20%) 4 (4%) 1 (1%) 
Bolat et al. 
[18] 
150 14 (9%) 4 (2.7%) 10 (6.7%) N.D. N.D. 
Ramraje and 
Kambale 
[50] 
2 2 
(100%) 
1 (50%) 0 1 (50%) 1 (50%) 
Baloch and 
LiVolsi [25] 
250  N.D. N.D. N.D. N.D. N.D. 
LiVolsi and 
Merino [15] 
300 N.D. N.D. N.D. N.D. N.D. 
*reported as vascular proliferation and/or vascular thrombosis 
 
